SecBot SecBot
SECBOTREPLAY Home › Report › EW

EW · Edwards Lifesciences Corp filed a definitive proxy statement (DEFA14A)…

Edwards Lifesciences Corp · DEFA14A filed Mar 26, 2026 at 16:06 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Mar 26, 2026 at 16:06 ET

Edwards Lifesciences Corp filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting of Stockholders, scheduled for May 7, 2026. The filing outlines four proposals for shareholder vote: election of nine directors, an advisory vote on executive compensation, ratification of the independent auditor, and approval of an amended long-term stock incentive program. The board recommends voting in favor of all proposals.

  • Filing is a definitive proxy statement (DEFA14A) for the 2026 Annual Meeting of Stockholders.
  • Meeting is scheduled for May 7, 2026, and will be held via webcast.
  • Proposals include the election of nine directors, an advisory vote on executive compensation, ratification of the independent auditor, and approval of an amended long-term stock incentive program.
  • The board of directors recommends a vote in favor of all proposals.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access